Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | +21.68% | +19.48% | -45.71% |
Apr. 09 | Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT | CI |
Apr. 08 | Declaration of Voting Results by Seres Therapeutics | CI |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.